US Air Force’s AFWERX Program Awards Polaris Genomics with Contract for Technology Innovation & Acceleration

January 5, 2022

Polaris Genomics is honored to have recently been selected as a funding recipient and participant of the United States Air Force program, AFWERX Program. Over a period running now through February 2022, Polaris will be awarded $50,000 as part of AFWERX’s DoD Small Business Innovation Research (SBIR), continuing its innovation and accelerating research of precision health solutions for advancements in the screening and treatment of behavioral health conditions like PTSD.

Notably, out of 1,234 proposals received by AFWERX’s AFVentures Program, Polaris is among an esteemed 320 technology businesses that were selected to participate in the current cohort.

“We are honored to have been selected. This Phase I award will allow us to find the right Air Force partner to further refine our objective tools to identify those at greatest risk for PTSD,” said Polaris Chief Medical Officer Dr Anne Naclerio, a retired Army veteran, operating as the Principal Investigator for this effort. “They share our commitment to earlier recognition and intervention of those suffering in silence.”

The company’s CEO Charles Cathlin is also a retired veteran and a graduate of the United States Air Force Academy, class of 1995.

ABOUT POLARIS GENOMICS

Polaris Genomics is a veteran-led business powerhouse comprising respected thought leaders who aim their passion for public health & medical research toward illuminating precision innovation for the benefit of the greater good. Products & services include:

  • TruGen-1: A 1003-gene panel that supports genomic research across a spectrum of neuropsychiatric conditions.
  • PTS-ID: A genomics test that provides objective information to help clinicians confidently and quickly assess patients with cortisol dysregulation associated with PTSD.
  • TruNorth Platform: A bioinformatics engine that provides comprehensive utilization of integrated data sources to create a complete picture of patient health and PTSD risk.
  • Endeavor Lab: Our high-complexity CLIA lab offers a wide variety of genomic sequencing, analysis, and lab testing services, including next-generation sequencing, CLIA / CAP clinical genetic testing, and assay processing.
  • And now, SalivaDirect PCR Covid-19 testing in support of healthier communities amid the pandemic.

Learn more about Polaris and its team at PolarisGenomics.com & stay connected at @PolarisGenomics.

ABOUT AFWERX

AFWERX is a United States Air Force program with the goal of fostering a culture of innovation within the service. The initiative is intended to circumvent bureaucracy and engage new entrepreneurs in Air Force programs. The goal of the programs under the AFWERX umbrella is to develop effective solutions to the challenges facing the service through partnerships with private sector business entities, with particular emphasis being placed on collaboration with technology startups. Learn more at https://afwerx.com/afventures-overview/.

Press Contact

Jen Williams
jen@polarisgenomics.com
+1 802 355 5072

Additional Reading

Polaris Genomics Advances Mental Health Biomarker Discovery

For decades, psychiatry has struggled with a critical gap: unlike cardiology or oncology, there are no molecular biomarkers to guide diagnosis or treatment. Polaris Genomics was founded to change that, and our mission recently earned global recognition as we progress...

Conference Posters for Review

Our scientific team is often invited to present posters at a range of academic, pharma, and clinical research conferences focused on neuroscience and mental and brain health. If you have not been able to meet them in person and see our technical information firsthand,...